About Pelvalon

About company

Founded in 2010, Pelvalon’s innovative new technology originated from Stanford University’s Biodesign program, a collaboration between the schools of Medicine and Engineering. The Biodesign program encourages the development of user-driven solutions to unmet medical needs, and they are proud to carry on the tradition of biomedical innovation. Pelvalon is privately held, and their investors include Norwich Ventures, a specialized venture capital firm focused on medical technology.